neoantigens

Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of-its-Kind Neoantigen Creation Approaches
PR Newswire
Thu, 01/26/23 - 10:44 am
Grey Wolf Therapeutics
cancer
funding
neoantigens
Gritstone posts 'one of the most potent immunogenic-responses for a neoantigen vaccine'
Fierce Biotech
Fri, 12/13/19 - 09:19 pm
Gritstone Oncology
solid tumors
vaccines
neoantigens
Neon and Neurotrope await signs of proof of concept
EP Vantage
Sat, 07/13/19 - 11:19 am
Neon Therapeutics
neoantigens
Neurotrope BioScience
Alzheimer's disease
Neon Therapeutics bags a $70M round for early-stage neoantigen research
Endpoints
Thu, 01/5/17 - 09:35 am
Neon Therapeutics
neoantigens
R&D
NEO-PV-01